Your search history is turned on.
Date: May 8, 2024 Jurisdictions: All jurisdictions
Exhibit 99.1 MindMed Reports First Quarter 2024 Financial Results and Business Updates --Announced positive Phase 2b clinical trial results for MM120 in Generalized Anxiety Disorder (GAD), demonstrating clinically and statistically significant activity through 12 weeks after treatment-- --The U.S. Food and...
Exhibit 31.2 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Carrie F. Liao, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Mind Medicine (Mindmed) Inc., (the Company) for the period ending March 31, 2024; 2. Based on my knowled...
Exhibit 31.1 CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Robert Barrow, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Mind Medicine (Mindmed) Inc., (the Company) for the period ending March 31, 2024; 2. Based on my knowledg...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ...
16 Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations. The following discussion should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included elsewhere in this Quarterly Report. This Quarterly Report, including the following sections, contains forward- looking statements. These state...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2024 MIND MEDICINE (MINDMED) INC. (Exact name of Registrant as Specified in Its Charter) British Columbia, Canada 001-40360 98-15...
Date: April 26, 2024 Jurisdictions: All jurisdictions
Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY V50039-P01355 2. To appoint KPMG LLP as independent registered public accounting firm (the Auditor) for the Company until the 2025 annua...
(1) (2) (3) (4) TABLE OF CONTENTS MIND MEDICINE (MINDMED) INC. One World Trade Center, Suite 8500 New York, New York 10007 (202) 572-3111 NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS To be held on June 10, 2024 at 10:00 a.m. Eastern Time. Dear Shareholder: You are cordially invited to attend the Annual General and Special Meeti...